Press Inquiry Form
If you are a journalist, editor, or media representative interested in covering AIMA and our innovations, please fill out the form below. We will get back to you as soon as possible.
A Tool for Diagnostic Optimization
Enhances the accuracy and speed of test interpretation.
Early Access
Suitable for those who monitor their health or are undergoing treatment.
Partnership with One of Eastern Europe’s Largest and Most Respected Laboratory Networks
Aima Diagnostics announces a partnership with ArtMediuz, one of the largest and most reputable laboratory networks in Eastern Europe, comprising 30 laboratories across 17 cities.
This collaboration marks a significant milestone in the advancement of AI-powered laboratory test interpretation technologies. Together, we are building a bridge between artificial intelligence and clinical expertise — ensuring an unprecedented level of diagnostic precision.
What makes this partnership especially valuable is the evidence-based, detail-oriented approach ArtMediuz has taken in integrating with Aima Diagnostics. The network is also engaging leading experts in hematology and laboratory medicine to ensure that AI-driven blood test interpretation is not only technically impeccable but also deeply aligned with the real needs of physicians and patients — reflecting the full spectrum of clinical nuance and practical experience.
With access to large-scale real-world laboratory data and decades of professional expertise, this partnership enables continuous refinement of Aima Diagnostics’ algorithms, adapting them to specific clinical contexts, population characteristics, and evolving medical standards.
For patients, this means a new level of diagnostic accuracy and personalization.
For physicians, it provides an intelligent decision-support tool grounded in the principles of precision, reliability, and trust — the core values of modern laboratory medicine.
Where Clinical Expertise Meets Artificial Intelligence:
30 Laboratories
17 Cities
Millions of Blood Tests
15.10.2025
This collaboration marks a significant milestone in the advancement of AI-powered laboratory test interpretation technologies. Together, we are building a bridge between artificial intelligence and clinical expertise — ensuring an unprecedented level of diagnostic precision.
What makes this partnership especially valuable is the evidence-based, detail-oriented approach ArtMediuz has taken in integrating with Aima Diagnostics. The network is also engaging leading experts in hematology and laboratory medicine to ensure that AI-driven blood test interpretation is not only technically impeccable but also deeply aligned with the real needs of physicians and patients — reflecting the full spectrum of clinical nuance and practical experience.
With access to large-scale real-world laboratory data and decades of professional expertise, this partnership enables continuous refinement of Aima Diagnostics’ algorithms, adapting them to specific clinical contexts, population characteristics, and evolving medical standards.
For patients, this means a new level of diagnostic accuracy and personalization.
For physicians, it provides an intelligent decision-support tool grounded in the principles of precision, reliability, and trust — the core values of modern laboratory medicine.
Where Clinical Expertise Meets Artificial Intelligence:
30 Laboratories
17 Cities
Millions of Blood Tests
15.10.2025
Understand Your Blood
Latest insights into blood test interpretation
- A medical center specializing in women’s health for over 25 years.
- Interpretation of Analyses for private Individuals, doctors, clinics, labs
- Personalization and historical data in test interpretation reveal hidden health issues.
- Behind the familiar headlines of infectious diseases, cancer, and cardiovascular disorders lies a problem whose magnitude is strikingly underestimated by the general public.
- Explore the latest 2025 insights on PCOS diagnosis, focusing on hormonal levels like AMH, LH/FSH, and androgens. Learn how advanced tools like Aima Diagnostics ensure precise interpretation of lab results for accurate polycystic ovary syndrome diagnosis
- According to data from the U.S. National Academies of Sciences, up to 15–20% of medical errors are associated with incorrect interpretation of results.
- How Aima Diagnostics' AI detected hidden anemia in a 40-year-old man's blood test, preventing a late diagnosis. Read the personalized diagnostics case study.
- Understand your blood test results with this expert guide. Learn about CBC, CMP, reference ranges, and what high/low values indicate for anemia, diabetes, and more.
- Learn how to interpret hCG, AMH, and progesterone tests for fertility with this expert guide. Discover what low AMH (<1.5 ng/mL) means, how to track hCG doubling, and the role of progesterone in pregnancy.
- Discover how to understand TSH, estrogen, and progesterone test results with this expert guide.
- Discover the most important blood tests for women aged 20–30, 30–40, and 40–50. Based on research from Harvard Medical School, Mayo Clinic, and WHO guidelines.
- Discover how AI-powered blood diagnostics can extend your life by monitoring biomarkers, assessing biological age, and predicting risks.
- Version 1.2 | July 2025
Developed by AIMA Diagnostics, Oslo, Norway - Rapid blood diagnostics in war and crisis zones: Ukraine, Sudan, Syria
- Genomic profiling, AI (Aima Diagnostics), non-invasive methods, and portable tech enhance early detection and accuracy.
- What do high platelets and white blood cells mean?
- Difference between reference intervals and normal values in blood tests. Understand how personalized ranges improve diagnosis accuracy. A guide for medical professionals.
- How to detect anemia from blood test results. Understand CBC, MCV, ferritin, and how Aima Diagnostics uses AI for faster, accurate interpretation.
- Explore causes, symptoms, diagnosis, and modern treatments for low hemoglobin and anemia. Updated clinical guide for physicians and healthcare professionals.
- A detailed review of key inflammatory blood markers—CRP, ESR, PCT, IL-6, and more. Clinical relevance, limitations, and interpretation for healthcare professionals.
- Explore key blood parameters and their diagnostic value, enhanced by AIMA, the first patented AI platform for precise, early blood analysis.
- Powerful tool for insurance companies, enabling significant cost reductions through early diagnostics, accurate risk assessment, fraud prevention, and process optimization.
- Explore RDW's role in diagnosing anemias and systemic diseases with clinical significance, enhanced by AI like Aima for precision.
- Modern medicine is making a significant leap forward with the integration of advanced technologies such as artificial intelligence (AI) in blood analysis.
- Diagnostic errors in blood analysis may lead to misdiagnosis, treatment delays, and exacerbated chronic conditions. This article analyzes pre-analytical and interpretive errors, their clinical impact, and the role of AI in enhancing precision and mitigating risks.
- Unveiling flaws in blood diagnostics, this piece explores AI, automation, and portable tech as keys to sharper, faster, and fairer testing.
- This in-depth analysis explores the CBC, a vital diagnostic tool, detailing its key parameters, reference ranges, and clinical insights for healthcare professionals.
- Сritical parameter derived from the Complete Blood Count (CBC), representing the concentration of hemoglobin within the erythrocyte mass.
- Blood analysis remains a cornerstone of clinical medicine, facilitating the diagnosis of hematological, infectious, and systemic diseases.